 | • レポートコード：MRC2-11QY04305 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は肺炎治療薬のグローバル市場について調査・分析したレポートです。種類別（ワクチン、抗感染薬、酸素療法）市場規模、用途別（病院、診療所、医療センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別肺炎治療薬の競争状況、市場シェア ・世界の肺炎治療薬市場：種類別市場規模 2015年-2020年（ワクチン、抗感染薬、酸素療法） ・世界の肺炎治療薬市場：種類別市場規模予測 2021年-2026年（ワクチン、抗感染薬、酸素療法） ・世界の肺炎治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、医療センター、その他） ・世界の肺炎治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、医療センター、その他） ・北米の肺炎治療薬市場分析：米国、カナダ ・ヨーロッパの肺炎治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの肺炎治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の肺炎治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの肺炎治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline、Merck Sharp & Dohme、Novartis、Pfizer、AstraZeneca、Bayer、Biotest、Tetraphase Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Pneumonia is a respiratory disease characterized by inflammation of air sacs in lungs due to bacterial or viral infection.
The emergence of advanced diagnostic techniques to be one of the primary factors fueling the growth of the pneumonia therapeutics market in the coming years.
Market Analysis and Insights: Global Pneumonia Therapeutics Market
The global Pneumonia Therapeutics market size is projected to reach US$ 12870 million by 2026, from US$ 12000 million in 2020, at a CAGR of 6.7%% during 2021-2026.
Global Pneumonia Therapeutics Scope and Market Size
Pneumonia Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pneumonia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
GlaxoSmithKline
Merck Sharp & Dohme
Novartis
Pfizer
AstraZeneca
Bayer
Biotest
Tetraphase Pharmaceuticals
Market segment by Type, the product can be split into
Vaccines
Anti-Infectives
Oxygen Therapy
Market segment by Application, split into
Hospital
Clinic
Medical Center
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pneumonia Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Pneumonia Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Vaccines
1.4.3 Anti-Infectives
1.4.4 Oxygen Therapy
1.5 Market by Application
1.5.1 Global Pneumonia Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Medical Center
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Pneumonia Therapeutics Market Perspective (2015-2026)
2.2 Global Pneumonia Therapeutics Growth Trends by Regions
2.2.1 Pneumonia Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pneumonia Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Pneumonia Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pneumonia Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Pneumonia Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Pneumonia Therapeutics Players by Market Size
3.1.1 Global Top Pneumonia Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Pneumonia Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Pneumonia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pneumonia Therapeutics Market Concentration Ratio
3.2.1 Global Pneumonia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pneumonia Therapeutics Revenue in 2019
3.3 Pneumonia Therapeutics Key Players Head office and Area Served
3.4 Key Players Pneumonia Therapeutics Product Solution and Service
3.5 Date of Enter into Pneumonia Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pneumonia Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Pneumonia Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Pneumonia Therapeutics Market Size by Application (2015-2020)
5.2 Global Pneumonia Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Pneumonia Therapeutics Market Size (2015-2020)
6.2 Pneumonia Therapeutics Key Players in North America (2019-2020)
6.3 North America Pneumonia Therapeutics Market Size by Type (2015-2020)
6.4 North America Pneumonia Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Pneumonia Therapeutics Market Size (2015-2020)
7.2 Pneumonia Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Pneumonia Therapeutics Market Size by Type (2015-2020)
7.4 Europe Pneumonia Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Pneumonia Therapeutics Market Size (2015-2020)
8.2 Pneumonia Therapeutics Key Players in China (2019-2020)
8.3 China Pneumonia Therapeutics Market Size by Type (2015-2020)
8.4 China Pneumonia Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Pneumonia Therapeutics Market Size (2015-2020)
9.2 Pneumonia Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Pneumonia Therapeutics Market Size by Type (2015-2020)
9.4 Japan Pneumonia Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Pneumonia Therapeutics Market Size (2015-2020)
10.2 Pneumonia Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pneumonia Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Pneumonia Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Pneumonia Therapeutics Market Size (2015-2020)
11.2 Pneumonia Therapeutics Key Players in India (2019-2020)
11.3 India Pneumonia Therapeutics Market Size by Type (2015-2020)
11.4 India Pneumonia Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Pneumonia Therapeutics Market Size (2015-2020)
12.2 Pneumonia Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Pneumonia Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Pneumonia Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview
13.1.3 GlaxoSmithKline Pneumonia Therapeutics Introduction
13.1.4 GlaxoSmithKline Revenue in Pneumonia Therapeutics Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Merck Sharp & Dohme
13.2.1 Merck Sharp & Dohme Company Details
13.2.2 Merck Sharp & Dohme Business Overview
13.2.3 Merck Sharp & Dohme Pneumonia Therapeutics Introduction
13.2.4 Merck Sharp & Dohme Revenue in Pneumonia Therapeutics Business (2015-2020)
13.2.5 Merck Sharp & Dohme Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Pneumonia Therapeutics Introduction
13.3.4 Novartis Revenue in Pneumonia Therapeutics Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Pneumonia Therapeutics Introduction
13.4.4 Pfizer Revenue in Pneumonia Therapeutics Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 AstraZeneca
13.5.1 AstraZeneca Company Details
13.5.2 AstraZeneca Business Overview
13.5.3 AstraZeneca Pneumonia Therapeutics Introduction
13.5.4 AstraZeneca Revenue in Pneumonia Therapeutics Business (2015-2020)
13.5.5 AstraZeneca Recent Development
13.6 Bayer
13.6.1 Bayer Company Details
13.6.2 Bayer Business Overview
13.6.3 Bayer Pneumonia Therapeutics Introduction
13.6.4 Bayer Revenue in Pneumonia Therapeutics Business (2015-2020)
13.6.5 Bayer Recent Development
13.7 Biotest
13.7.1 Biotest Company Details
13.7.2 Biotest Business Overview
13.7.3 Biotest Pneumonia Therapeutics Introduction
13.7.4 Biotest Revenue in Pneumonia Therapeutics Business (2015-2020)
13.7.5 Biotest Recent Development
13.8 Tetraphase Pharmaceuticals
13.8.1 Tetraphase Pharmaceuticals Company Details
13.8.2 Tetraphase Pharmaceuticals Business Overview
13.8.3 Tetraphase Pharmaceuticals Pneumonia Therapeutics Introduction
13.8.4 Tetraphase Pharmaceuticals Revenue in Pneumonia Therapeutics Business (2015-2020)
13.8.5 Tetraphase Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Pneumonia Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Pneumonia Therapeutics Revenue
Table 3. Ranking of Global Top Pneumonia Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pneumonia Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Vaccines
Table 6. Key Players of Anti-Infectives
Table 7. Key Players of Oxygen Therapy
Table 8. Global Pneumonia Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Pneumonia Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Pneumonia Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Pneumonia Therapeutics Market Share by Regions (2015-2020)
Table 12. Global Pneumonia Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Pneumonia Therapeutics Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Pneumonia Therapeutics Market Growth Strategy
Table 18. Main Points Interviewed from Key Pneumonia Therapeutics Players
Table 19. Global Pneumonia Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 20. Global Pneumonia Therapeutics Market Share by Players (2015-2020)
Table 21. Global Top Pneumonia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia Therapeutics as of 2019)
Table 22. Global Pneumonia Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Pneumonia Therapeutics Product Solution and Service
Table 25. Date of Enter into Pneumonia Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pneumonia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 28. Global Pneumonia Therapeutics Market Size Share by Type (2015-2020)
Table 29. Global Pneumonia Therapeutics Revenue Market Share by Type (2021-2026)
Table 30. Global Pneumonia Therapeutics Market Size Share by Application (2015-2020)
Table 31. Global Pneumonia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 32. Global Pneumonia Therapeutics Market Size Share by Application (2021-2026)
Table 33. North America Key Players Pneumonia Therapeutics Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Pneumonia Therapeutics Market Share (2019-2020)
Table 35. North America Pneumonia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 36. North America Pneumonia Therapeutics Market Share by Type (2015-2020)
Table 37. North America Pneumonia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. North America Pneumonia Therapeutics Market Share by Application (2015-2020)
Table 39. Europe Key Players Pneumonia Therapeutics Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Pneumonia Therapeutics Market Share (2019-2020)
Table 41. Europe Pneumonia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Pneumonia Therapeutics Market Share by Type (2015-2020)
Table 43. Europe Pneumonia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Pneumonia Therapeutics Market Share by Application (2015-2020)
Table 45. China Key Players Pneumonia Therapeutics Revenue (2019-2020) (Million US$)
Table 46. China Key Players Pneumonia Therapeutics Market Share (2019-2020)
Table 47. China Pneumonia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. China Pneumonia Therapeutics Market Share by Type (2015-2020)
Table 49. China Pneumonia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. China Pneumonia Therapeutics Market Share by Application (2015-2020)
Table 51. Japan Key Players Pneumonia Therapeutics Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Pneumonia Therapeutics Market Share (2019-2020)
Table 53. Japan Pneumonia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Pneumonia Therapeutics Market Share by Type (2015-2020)
Table 55. Japan Pneumonia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Pneumonia Therapeutics Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Pneumonia Therapeutics Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Pneumonia Therapeutics Market Share (2019-2020)
Table 59. Southeast Asia Pneumonia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Pneumonia Therapeutics Market Share by Type (2015-2020)
Table 61. Southeast Asia Pneumonia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Pneumonia Therapeutics Market Share by Application (2015-2020)
Table 63. India Key Players Pneumonia Therapeutics Revenue (2019-2020) (Million US$)
Table 64. India Key Players Pneumonia Therapeutics Market Share (2019-2020)
Table 65. India Pneumonia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 66. India Pneumonia Therapeutics Market Share by Type (2015-2020)
Table 67. India Pneumonia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 68. India Pneumonia Therapeutics Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Pneumonia Therapeutics Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Pneumonia Therapeutics Market Share (2019-2020)
Table 71. Central & South America Pneumonia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Pneumonia Therapeutics Market Share by Type (2015-2020)
Table 73. Central & South America Pneumonia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Pneumonia Therapeutics Market Share by Application (2015-2020)
Table 75. GlaxoSmithKline Company Details
Table 76. GlaxoSmithKline Business Overview
Table 77. GlaxoSmithKline Product
Table 78. GlaxoSmithKline Revenue in Pneumonia Therapeutics Business (2015-2020) (Million US$)
Table 79. GlaxoSmithKline Recent Development
Table 80. Merck Sharp & Dohme Company Details
Table 81. Merck Sharp & Dohme Business Overview
Table 82. Merck Sharp & Dohme Product
Table 83. Merck Sharp & Dohme Revenue in Pneumonia Therapeutics Business (2015-2020) (Million US$)
Table 84. Merck Sharp & Dohme Recent Development
Table 85. Novartis Company Details
Table 86. Novartis Business Overview
Table 87. Novartis Product
Table 88. Novartis Revenue in Pneumonia Therapeutics Business (2015-2020) (Million US$)
Table 89. Novartis Recent Development
Table 90. Pfizer Company Details
Table 91. Pfizer Business Overview
Table 92. Pfizer Product
Table 93. Pfizer Revenue in Pneumonia Therapeutics Business (2015-2020) (Million US$)
Table 94. Pfizer Recent Development
Table 95. AstraZeneca Company Details
Table 96. AstraZeneca Business Overview
Table 97. AstraZeneca Product
Table 98. AstraZeneca Revenue in Pneumonia Therapeutics Business (2015-2020) (Million US$)
Table 99. AstraZeneca Recent Development
Table 100. Bayer Company Details
Table 101. Bayer Business Overview
Table 102. Bayer Product
Table 103. Bayer Revenue in Pneumonia Therapeutics Business (2015-2020) (Million US$)
Table 104. Bayer Recent Development
Table 105. Biotest Company Details
Table 106. Biotest Business Overview
Table 107. Biotest Product
Table 108. Biotest Revenue in Pneumonia Therapeutics Business (2015-2020) (Million US$)
Table 109. Biotest Recent Development
Table 110. Tetraphase Pharmaceuticals Business Overview
Table 111. Tetraphase Pharmaceuticals Product
Table 112. Tetraphase Pharmaceuticals Company Details
Table 113. Tetraphase Pharmaceuticals Revenue in Pneumonia Therapeutics Business (2015-2020) (Million US$)
Table 114. Tetraphase Pharmaceuticals Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pneumonia Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Vaccines Features
Figure 3. Anti-Infectives Features
Figure 4. Oxygen Therapy Features
Figure 5. Global Pneumonia Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Medical Center Case Studies
Figure 9. Other Case Studies
Figure 10. Pneumonia Therapeutics Report Years Considered
Figure 11. Global Pneumonia Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Pneumonia Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Pneumonia Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Pneumonia Therapeutics Market Share by Players in 2019
Figure 16. Global Top Pneumonia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Pneumonia Therapeutics Revenue in 2019
Figure 18. North America Pneumonia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Pneumonia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Pneumonia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Pneumonia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Pneumonia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Pneumonia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Pneumonia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
細菌性肺炎治療薬の世界市場（～2026年） Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affec…- 人工呼吸器関連肺炎（VAP）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ventilator Associated Pneumonia (VAP) Therapeutics Market The global Ventilator Associated Pneumonia (VAP) Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ventilator As…
- 市中肺炎（CAP）の世界市場（～2026年） Community-acquired pneumonia (CAP) refers to pneumonia (any of several lung diseases) contracted by a person with little contact with the healthcare system. The market of CAP treatment and diagnosis in further segmented with respect to major geographies of North America, Europe, Asia-Pacific, and La…
- 肺炎の世界市場（～2026年） Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affec…
- 院内肺炎予防の世界市場（～2026年） HAP is defined as a lower respiratory infection, which does not incubate at the time of hospital admission but presents clinically 2 or more days after hospitalization.Incidence of HAP is more prevalent in the medical and surgical Intensive Care Units, and results in additional cost to the healthcar…